Mississippi withdraws proposed Medicaid rate cuts

July 31, 2008

A court had granted Medicaid providers a preliminary injunction against the proposed cuts.

Government to pay doctors to use e-prescriptions

July 31, 2008

Move comes as part of a broader effort to encourage the adoption of health information technology.

Rite Aid to push oral care with free resources

July 31, 2008

Rite Aid drugstores will offer patients a free Oral Care Guide and an Oral Care Tip Book.

Consumers warned not to take Viapro capsules

July 31, 2008

One lot was found to contain a potentially harmful, undeclared ingredient.

Anemia drugs to be restricted to fewer patients

July 31, 2008

Erythropoiesis stimulating agents will bear stricter labeling.

FDA Consumer Corner: Nonoxynol 9 Contraceptives: No Protection against HIV and Other STDs

July 31, 2008

The Food and Drug Administration wants to be sure that consumers know about new warnings on over-the-counter vaginal contraceptive products that contain the spermicide ingredient nonoxynol 9 (N9). These products include spermicidal gels, foams, film...

Preventing Medical Errors: Potential Problems with Insulin Pens in Hospitals

July 31, 2008

In a recent article, the Institute for Safe Medication Practices (ISMP) highlighted several potential safety problems when hospitals switch from multiple dose vials of insulin to insulin pens. ISMP points out that there are certain safety advant...

Preventing Medical Errors: Danger Giving Topical Thrombin Intravascularly

July 31, 2008

The Institute for Safe Medication Practices (ISMP) recently warned about the dangers of accidentally giving topical thrombin intravascularly. Thrombin applied topically can help stop oozing blood and minor bleeding from capillaries and small veins. ...

Recalls and Safety Alerts: Possible Association between TNF Blockers and Cancer

July 31, 2008

FDA has informed healthcare professionals that it is investigating a possible association between drugs that block tumor necrosis factor (TNF) and the development of lymphoma and other cancers in children and young adults. This is part of FDA's ...

Recalls and Safety Alerts: Cellcept and Myfortic Linked to Birth Defects and Fetal Loss

July 31, 2008

FDA is advising healthcare professionals about an increased risk of fetal harm when women become pregnant while being treated with the immunosuppressant drugs Cellcept (mycophenolate mofetil) or Myfortic (mycophenolic acid). Myfortic is approved t...

Next Page »